Manufacturing News of Note—Thermo Fisher closes on GSK plant; Vetter invests $100M; Lupin names ex-Apotex exec head of quality 

stocks
(Pixabay)

> Waltham, Massachusetts-based Thermo Fisher Scientific has completed its €90 million buyout of a GlaxoSmithKline API site in Cork, Ireland. Release 

> German CDMO Vetter says it will invest $100 million to upgrade its production lines at sites in Germany and the U.S. to increase filling capacity. Story

> Lupin, which has been struggling with manufacturing quality, has named as its new global head of quality Johnny Mikell. He comes from Apotex, another drugmaker with a history of FDA manufacturing issues. Release 

Whitepaper

Simplify and Accelerate Drug R&D With the MarkLogic Data Hub Service for Pharma R&D

Researchers are often unable to access the information they need. And, even when data does get consolidated, researchers find it difficult to sift through it all and make sense of it in order to confidently draw the right conclusions and share the right results. Discover how to quickly and easily find, synthesize, and share information—accelerating and improving R&D.

> Lupin has received a Form 483 with three observations for its Tarapur plant. Story 

> South Plainfield, New Jersey-based biotech PTC Therapeutics has struck a deal with Aldevron to manufacture its gene therapy portfolio. Release 

> Boehringer Ingelheim has completed a $76 million expansion at its plant at Athens, Georgia, which doubles its pet vaccine capacity. Release

> Merck KGaA’s MilliporeSigma has acquired for an undisclosed amount Wilbraham, Massachusetts-based FloDesign Sonics, which has developed an acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Release

Suggested Articles

Higher operating costs were behind a 17% slide in pretax profits last year at Allergan’s Mayo, Ireland, facility that produces Botox.

After a global scare over Zantac contamination, generic metformin could be next in line as regulators test for possible carcinogen contamination.

PCI Pharma Services debuts expansion of its plant in Rockford, Illinois.